(Q63593389)
Statements
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL747 in Subjects With Amyotrophic Lateral Sclerosis (English)
0 references
28 December 2018
0 references
August 2019
0 references
16
0 references
21 year
0 references
80 year
0 references